Join Clinical trials for Aspergillosis

All Categories Medical Conditions » Infectious Diseases » Aspergillosis

ATCF (Azole Therapy in Cystic Fibrosis)

Conditions: Cystic Fibrosis; Aspergillus Infections
Intervention: Drug: Itraconazole/voriconazole
Sponsors: Rennes University Hospital; Rennes University Hospital
Not yet recruiting - verified April 2012
Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates

Condition: Invasive Fungal Infection
Intervention: Drug: caspofungin
Sponsors: Radboud University; Radboud University
Recruiting - verified February 2012
Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease

Conditions: Invasive Pulmonary Aspergillosis; Chronic Obstructive Pulmonary Disease
Intervention: Drug: caspofungin
Sponsors: The First Affiliated Hospital of Guangzhou Medical University; The First Affiliated Hospital of Guangzhou Medical University; Merck
Recruiting - verified March 2012
Application of an Electronic Nose in the Early Detection of ASpergillosis

Condition: Pulmonary Invasive Aspergillosis
Intervention:
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified June 2011
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection

Conditions: Aspergillosis, Aspergilloma; Candidemia, Candidiasis; Cryptococcal Meningitis, Pulmonary Cryptococcosis; Fusariosis; Scedosporiosis
Interventions: Drug: Voriconazole; Drug: Voriconazole
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012
Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis

Condition: Fungal Infection
Intervention: Drug: caspofungin
Sponsors: Wuerzburg University Hospital; Wuerzburg University Hospital; Merck
Recruiting - verified July 2011
Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis

Condition: Invasive Pulmonary Aspergillosis
Intervention:
Sponsors: Universitaire Ziekenhuizen Leuven; Universitaire Ziekenhuizen Leuven
Recruiting - verified September 2011
A Study of MK-0991 in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)

Condition: Fungal Infection
Intervention: Drug: MK-0991 (caspofungin)
Sponsors: Merck; Merck
Recruiting - verified May 2012
Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

Condition: Invasive Fungal Infection
Intervention: Drug: voriconazole
Sponsors: Asan Medical Center; Asan Medical Center
Recruiting - verified February 2012
Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis

Condition: Cryptococcosis or Aspergillosis Infections
Intervention: Drug: SPK-843
Sponsors: Proaparts srl; Proaparts srl
Recruiting - verified June 2011
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

Condition: Invasive Aspergillosis
Intervention: Drug: Voriconazole
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Conditions: Aspergillosis; Invasive Fungal Infections
Intervention: Drug: isavuconazole
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc; Basilea Pharmaceutica
Recruiting - verified May 2012
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

Conditions: Graft Versus Host Disease; Infection; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Genetic: polymerase chain reaction; Other: bronchoalveolar lavage; Other: immunoenzyme technique; Other: laboratory biomarker analysis; Procedure: bronchoscopy; Procedure: management of therapy complications
Sponsors: National Cancer Institute (NCI); St. Bartholomew's Hospital
Recruiting - verified September 2007
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Conditions: Invasive Fungal Infection; Aspergillosis
Interventions: Drug: Isavuconazole; Drug: Voriconazole
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc; Basilea Pharmaceutica
Recruiting - verified May 2012